|
2023
|
Invention
|
Anti-garp-tgf-β1/pd-1 combination therapy. The present disclosure provides methods of treating ca... |
|
|
Invention
|
Anti-cd19 antibody drug conjugates. The present disclosure provides anti-CD19 antibody drug conju... |
|
|
Invention
|
Methods of treatment of non-small-cell lung carcinoma using telisotuzummab vedotin and osimertini... |
|
|
Invention
|
Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotin and osimertinib... |
|
|
Invention
|
Anti-cmet antibody drug conjugates and methods for their use.
The present disclosure provides an... |
|
2022
|
Invention
|
Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotin.
The present d... |
|
|
Invention
|
Methods of treatment of non-small-cell lung carcinoma using telisotuzumab vedotin. The present di... |
|
2021
|
Invention
|
Anti-cd40 antibodies and their uses.
The present disclosure provides novel anti-CD40 antibodies,... |
|
|
Invention
|
Anti-ox40 antibodies and their uses.
The present disclosure provides novel anti-OX40 antibodies,... |
|
|
Invention
|
Abt-165 in combination with folinic acid, 5-fluorouracil, and irinotecan for the treatment of can... |
|
2020
|
Invention
|
Anti-cd40 antibody and their uses.
The present disclosure provides novel anti-CD40 antibodies, c... |
|
|
Invention
|
Anti-pd-1 antibodies and their uses.
The present disclosure provides novel anti-PD-1 antibodies,... |
|
|
Invention
|
Dac hyp compositions and methods.
The present disclosure relates to compositions of daclizumab s... |
|
2019
|
Invention
|
Anti-ox40 antibodies and their uses. The present disclosure provides novel anti-OX40 antibodies, ... |
|
|
Invention
|
Anti-pd-1 antibodies and their uses. The present disclosure provides novel anti-PD-1 antibodies, ... |
|
|
Invention
|
Anti-cd40 antibodies. The present disclosure provides novel anti-CD40 antibodies, compositions in... |
|
|
Invention
|
Therapeutic use of anti-cs1 antibodies.
The present invention is directed to antagonists of CS1 ... |
|
|
Invention
|
Anti-cd40 antibody. The present disclosure provides novel anti-CD40 antibodies, compositions incl... |
|
|
Invention
|
Anti-cmet antibody drug conjugates and methods for their use. The present disclosure provides ant... |
|
2018
|
Invention
|
Anti-hulrrc15 antibody drug conjugates and methods for their use. The present disclosure provides... |
|
|
Invention
|
Anti-hulrrc15 antibody drug conjugates and methods for their use.
The present disclosure provide... |
|
|
Invention
|
Vectors and host cells comprising a modified sv40 promoter for protein expression.
The present d... |
|
|
Invention
|
Nucleic acid molecules encoding anti-cd40 antibodies. The present disclosure provides novel anti-... |
|
|
Invention
|
Bispecific binding proteins that bind cd40 and mesothelin. The present disclosure provides bispec... |
|
|
Invention
|
Fc variants.
The present disclosure relates to polypeptide variants having modified Fc domains w... |
|
2017
|
Invention
|
Anti-cs1 antibodies and antibody drug conjugates. The present disclosure provides antibodies and ... |
|
|
Invention
|
Methods of treating progressive forms of multiple sclerosis.
The present disclosure relates to m... |
|
|
Invention
|
Anti-pd-1(cd279) antibodies. The present disclosure provides novel anti-PD-1 antibodies, composit... |
|
|
Invention
|
Compositions containing reduced amounts of daclizumab acidic isoforms and methods for preparing t... |
|
|
Invention
|
Anti-4-1bb antibodies and their uses. The present disclosure provides novel anti-4-1BB antibodies... |
